{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:33:34Z","timestamp":1761856414725,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.medcli.2019.04.007","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T10:17:55Z","timestamp":1559902675000},"page":"69-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Profilaxis secundaria de un s\u00edndrome coronario agudo durante la infusi\u00f3n de rituximab"],"prefix":"10.1016","volume":"154","author":[{"given":"Ana","family":"Triguero Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Gual Capllonch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Sancho C\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2019.04.007_bib0030","doi-asserted-by":"crossref","first-page":"7935","DOI":"10.1158\/1078-0432.CCR-08-1124","article-title":"A phase I-II study to determine the maximum tolerated infusion rate of rituximab with special emphasis on monitoring the effect of rituximab on cardiac function","volume":"14","author":"Siano","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.medcli.2019.04.007_bib0035","article-title":"A case of coronary vasospasm after repeat rituximab infusion","author":"Ke","year":"2015","journal-title":"Case Rep Cardiol"},{"key":"10.1016\/j.medcli.2019.04.007_bib0040","first-page":"187","article-title":"Rituximab-induced acute ST elevation myocardial infarction","volume":"15","author":"Keswan","year":"2015","journal-title":"Ochsner J"},{"issue":"Suppl 68","key":"10.1016\/j.medcli.2019.04.007_bib0045","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1016\/j.ihj.2015.10.374","article-title":"Updated cardiac concerns with rituximab use: A growing challenge","volume":"2","author":"Verma","year":"2016","journal-title":"Indian Heart J"},{"key":"10.1016\/j.medcli.2019.04.007_bib0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","article-title":"Rituximab maintenance for 2 years in patients with high burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): A phase 3, randomized controlled trial","volume":"377","author":"Salles","year":"2011","journal-title":"Lancet"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531930301X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531930301X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:49:41Z","timestamp":1758419381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577531930301X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S002577531930301X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2019.04.007","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profilaxis secundaria de un s\u00edndrome coronario agudo durante la infusi\u00f3n de rituximab","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2019.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}